As of Sep 22
| +0.18 / +1.67%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 26.00, with a high estimate of 29.00 and a low estimate of 19.00. The median estimate represents a +136.58% increase from the last price of 10.99.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.